SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

Sanofi Secures US Approval for Type 3 Gaucher Disease Treatment

Sanofi said it received US approval for the first treatment targeting neurological symptoms of Type 3 Gaucher disease.

SNY

Related stories